Abstract
Prostate cancer (PCa) is a disease in which understandings of what it means to be a man and structural inequalities affecting men from different groups intersect and interact in important and complex ways at every stage of the disease “journey” from first noticing a problem, to seeking help and obtaining a diagnosis through treatment to survivorship. PCa needs to be understood with reference to prevailing norms and enactments of masculinity and to the ethnicity and social class of the man with cancer. This chapter will provide basic information about the nature, symptoms and treatment of prostate cancer. It will discuss these in terms of their psychological and psychosocial impact on men and their families, with a particular focus on how concepts of masculinity as well as ethnicity, sexual orientation and gender identity shape these effects.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alibhai, S. M. H., Breunis, H., Timilshina, N., Marzouk, S., Stewart, D., Tannock, I., et al. (2010). Impact of androgen-deprivation therapy on cognitive function in men with nonmetastatic prostate cancer. Journal of Clinical Onclology,28, 5038–5045.
Allen, J. D., Kennedy, M., Wilson-Glover, A., & Gilligan, T. D. (2007). African-American men’s perceptions about prostate cancer: Implications for designing educational interventions. Social Science and Medicine,64, 2189–2200.
Asencio, M., Blank, T., Descartes, L., & Crawford, A. (2009). The prospect of prostate cancer: A challenge for gay men’s sexualities as they age. Sexuality Research & Social Policy,6(4), 38–51.
Bacon, C. G., Giovannucci, E., Testa, M., & Kawachi, I. (2001). The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer. Journal of Urology,166, 1804–1810.
Badr, H., & Carmack Taylor, C. L. (2009). Sexual dysfunction and spousal communication in couples coping with prostate cancer. Psycho-Oncology,18, 735–746.
Baker, R., Sinfield, P., Agarwal, S., Tarrant, C., Steward, W., Mellon, J. K., et al. (2007). Prostate cancer care: Improving measures of the patient experience. Report for the NHS Service Delivery and Organisation R&D (NCCSDO). London: SDO. www.sdo.nihr.ac.uk.
Banthia, R., Malcarne, V. L., Varni, J. W., Ko, C. M., Sadler, G. R., & Greenbergs, H. L. (2003). The effects of dyadic strength and coping styles on psychological distress in couples faced with prostate cancer. Journal of Behavioral Medicine,26(1), 31–52.
Barry, M. J. (2009). Screening for prostate cancer—The controversy that refuses to die. New England Journal of Medicine,360(13), 1351–1354.
Bennett, G., & Badger, T. A. (2005). Depression in men with prostate cancer. Oncology Nursing Forum,32, 545–556.
Blank, T. (2005). Gay men and prostate cancer: Invisible diversity. Journal of Clinical Oncology,12, 2593–2596.
Boehmer, U., & Clark, J. A. (2001). Married couples’ perspectives on prostate cancer diagnosis and treatment decision-making. Psycho-Oncology,10, 147–155.
Boehmer, U., Cooley, T. P., & Clark, M. A. (2012). Cancer and men who have sex with men: A systematic review. Lancet Oncology,13(12), e545–e553.
Bolla, M., Collette, L., Van Tienhoven, G., WArde, P., Dubois, J. B., Mirimanoff, R. O. M., et al. (2008). Ten year results of long-term androgen deprivation therapy with goserelin in patients with locally-advanced prostate cancer treated with radiotherapy: A phase III EORTC study. Radiation Oncology,72(Suppl. 1), S30–S31.
Cant, B., & Taket, A. (2006). Lesbian and gay experiences of primary care in one borough in North London, UK. Diversity in Health and Social Care,3(4), 271–279.
Cary, K. C., Singla, N., Cowan, J. E., Carroll, P. R., & Cooperberg, M. R. (2014). Impact of androgen deprivation therapy on mental and emotional well being in men with prostate cancer: Analysis from the CaPSURE registry. Journal of Urology,191, 964–970.
Casey, R. G., Corcoran, N. M., & Goldenberg, S. L. (2012). Quality of life issues in men undergoing androgen deprivation therapy a review. Asian Journal of Andrology,14(2), 226–231.
Cetin, K., Li, S., Blaes, A. H., Stryker, S., Liede, A., & Arneson, T. J. (2013). Prevalence of patients with nonmetastatic prostate cancer on androgen deprivation therapy in the United States. Urology,81(6), 1184–1189.
Chapple, A., & Ziebland, S. (2002). Prostate cancer: Embodied experience and perceptions of masculinity. Sociology of Health & Illness,24(6), 820–841.
Cherrier, M. M., Aubin, S., & Higano, C. S. (2009). Cognitive and mood changes in men undergoing intermittent combined androgen blockade for non-metastatic prostate cancer. Psycho-Oncology,18, 237–247.
Chinegwundoh, F., Enver, M., Lee, A., Nargund, V., Oliver, T., & Ben-Shlomo, Y. (2006). Risk and presenting features of prostate cancer amongst African-Caribbean, South Asian and European men in north-east London. British Journal of Urology International,98, 1216–1220.
Connolly, R. M., Carducci, M. A., & Antonarakis, E. S. (2012). Use of androgen deprivation therapy in prostate cancer: Indications and prevalence. Asian Journal of Andrology,14(2), 177–186.
CRUK Website. Retrieved December 2, 2017, from http://www.cancerresearchuk.org.
CRUK. (2018). Prostate cancer survival statistics. Retrieved December 9, 2018, from https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/prostate-cancer/survival#ref-0.
Davison, J. B., Gleave, M. E., Goldenberg, L. S., Degner, L. F., Hoffart, D., & Berkowitz, J. (2002). Assessing information and decision preferences of men with prostate cancer and their partners. Cancer Nursing,25(1), 42–49.
Dean, L., Meyer, I., Robinson, K., Sell, R., Sember, R., Silenzio, V., et al. (2000). Lesbian, gay, bisexual, and transgender health: Findings and concerns. Journal of the Gay and Lesbian Medical Association,4, 102–151.
Eton, D. T., & Lepore, S. J. (2002). Prostate cancer and health-related quality of life: A review of the literature. Psycho-Oncology,11, 307–326.
Fergus, K., Gray, R., & Fitch, M. (2002). Sexual dysfunction and the preservation of manhood: Experiences of men with prostate cancer. Journal of Health Psychology,7(3), 303–316.
Filiault, S. M., Drummond, M. J. N., & Smith, J. A. (2008). Gay men and prostate cancer: Voicing the concerns of a hidden population. Journal of Men’s Health,5(4), 327–332.
Frey, A. U., Sonksen, J., & Fode, M. (2014). Neglected side effects after radical prostatectomy: A systematic review. Journal of Sexual Medicine,11(2), 374–385.
Gannon, K., Glover, L., O’Neill, M., & Emberton, M. (2005). Lower urinary tract symptoms in men: Self-perceptions and the concept of bother. BJU International,96, 823–827.
Gannon, K., Guerro-Blanco, M., & Abel, P. D. (2010). Reconstructing masculinity following radical prostatectomy for prostate cancer. The Aging Male,13(4), 258–264.
Gore, J. L., Krupski, T., Kwan, L., Maliski, S., & Litwin, M. S. (2005). Partnership status influences quality of life in low-income, uninsured men with prostate cancer. Cancer,104(1), 191–198.
Green, H. J., Pakenham, K. I., Headley, B. C., Yaxley, J., Nicol, D. L., Mactaggart, P. N., et al. (2002). Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: A randomized controlled trial. BJU International,90, 427–432.
Grey, R. E., et al. (2002). Prostate cancer and erectile dysfunction: Men’s experiences. International Journal of Men’s Health,1(1), 15–29.
Hale, S., Groga, S., & Willott, S. (2010). Male GPs’ views on men seeking medical help: A qualitative study. British Journal of Health Psychology,15, 697–713.
Harden, J., Sanda, M. G., Wei, J. T., Yarandi, H. N., Hembroff, L., & Hardy, J. (2013). Survivorship after prostate cancer treatment: Spouses’ quality of life at 36 months. Oncology Nursing Forum,40(6), 567–573.
Harrison, S. E., Watson, E. K., Ward, A. M., Khan, N. F., Turner, D., Adams, E., et al. (2012). Cancer survivors’ experiences of discharge from hospital follow-up. European Journal of Cancer Care,21(3), 390–397.
Heaphy, B., Yip, A., & Thompson, D. (2003). Lesbian, gay and bisexual lives over 50. Nottingham: York House.
Herr, H. W. (1997). Quality of life in prostate cancer patients. CA: A Cancer Journal for Clinicians,47(4), 207–217.
Heslin, K. C., Gore, J. L., King, W. D., & Fox, S. A. (2008). Sexual orientation and testing for prostate and colorectal cancers among men in California. Medical Care,46(12), 1240–1248.
Holzbeierlein, J. M., Castle, E., & Thrasher, J. B. (2004). Complications of androgen deprivation therapy: Prevention and treatment. Oncology,18, 303–309.
Hudson, S. V., Miller, S. M., Hemler, J., Ferrante, J. M., Lyle, J., Oeffinger, K. C., et al. (2012). Adult cancer survivors discuss follow-up in primary care: ‘Not what I want, but maybe what I need’. Annals of Family Medicine,10(5), 418–427.
Huggins, C., & Hodges, C. V. (1941). Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Research,1(4), 293–297.
Jacobs, J. R., Banthia, R., Robins Sadler, G., Varni, J. W., et al. (2002). Problems associated with prostate cancer: Differences of opinion among health care providers, patients, and spouses. Journal of Cancer Education,17, 33–36.
Joly, F., Alibhai, S. M., Galica, J., Park, A., Yi, Q. L., Wagner, L., et al. (2006). Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with nonmetastatic prostate cancer. Journal of Urology,176(6 pt 1), 2443–2447.
Jowett, A., & Peel, E. (2009). Chronic illness in non-heterosexual contexts: An online survey of experiences. Feminism and Psychology,19(4), 454–474.
Klitzman, R., & Greenberg, J. (2002). Patterns of communication between gay and lesbian patients and their health care providers. Journal of Homosexuality,42, 65–75.
Krongrad, A., Lai, H., Burke, M. A., Goodkin, K., & Lai, S. (1996). Marriage and mortality in prostate cancer. The Journal of Urology,156(5), 1696–1700.
Lavery, H. J., & Cooperberg, M. R. (2017). Clinically localized prostate cancer in 2017: A review of comparative effectiveness. Urologic Oncology,35(2), 40–41.
Lee, M., Jim, H. S., Fishman, M., et al. (2015). Depressive symptomatology in men receiving androgen deprivation therapy for prostate cancer: A controlled comparison. Psycho-Oncology,24, 472–477.
Macefield, R. C., Metcalfe, C., Lane, J. A., Donovan, J. L., Avery, K. N. L., Blazeby, J. M., et al. (2010). Impact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result. British Journal of Cancer,102, 1335–1340.
Malcarne, V. L., Banthia, R., Varni, J. W., Robins Sadler, G., Greenbergs, H. L., & Ko, C. M. (2002). Problem-solving skills and emotional distress in spouses of men with prostate cancer. Journal of Cancer Education,17, 150–154.
Messing, E. M., Manola, J., Sarosdy, M., Wilding, G., Crawford, E. D., & Trump, D. (1999). Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. New England Journal of Medicine,341, 1781–1788.
Nead, K. T., Gaskin, G., Chester, C., Swisher-McClure, S., Leeper, N. J., & Shah, N. H. (2017). Association between androgen deprivation therapy and risk of dementia. JAMA Oncology,3(1), 49–55.
Neville, S., & Henrickson, M. (2006). Perceptions of lesbian, gay and bisexual people of primary healthcare services. Journal of Advanced Nursing,55(4), 407–415.
Ng, E., Woo, H. H., Turner, S., Leong, E., Jackson, M., & Spry, N. (2012). The influence of testosterone suppression and recovery on sexual function in men with prostate cancer: Observations from a prospective study in men undergoing intermittent androgen suppression. Journal of Urology,187, 2162–2166.
Norcross, W., Ramirez, C., & Palinkas, L. A. (1996). The influence of women on the health-care seeking behaviour of men. Journal of Family Practice,43(5), 475–480.
Oliffe, J. (2006). Embodied masculinity and androgen deprivation therapy. Sociology of Health & Illness,28, 410–432.
Prostate Cancer UK. (2014). Retrieved May 30, 2018, from https://prostatecanceruk.org/for-health-professionals/our-projects/public-awareness-study.
Riechers, E. A. (2004). Including partners into the diagnosis of prostate cancer: A review of the literature to provide a model of care. Urologic Nursing,24(1), 22–38.
Salminen, E. K., Portin, R. I., Koskinen, A., Helenius, H., & Nurmi, M. (2003). Androgen deprivation and cognition in prostate cancer. British Journal of Cancer,89, 971–976.
Salminen, E. K., Portin, R. I., Koskinen, A., Helenius, H., & Nurmi, M. (2004). Associations between serum testosterone fall and cognitive function in prostate cancer patients. Clinical Cancer Research,10, 7575–7582.
Salminen, E. K., Portin, R. I., Koskinen, A., Helenius, H., & Nurmi, M. (2005). Estradiol and cognition during androgen deprivation in men with prostate carcinoma. Cancer,103, 1381–1387.
Sanda, M. G., Dunn, R. L., Michalski, J., et al. (2008). Quality of life and satisfaction with outcome among prostate cancer survivors. New England Journal of Medicine, 358, 1250–1261.
Seymour-Smith, S., Brown, D., Cosma, G., Shopland, N., Battersby, S., & Burton, A. (2016). “Our people has got to come to terms with that”: Changing perceptions of the digital rectal examination as a barrier to prostate cancer diagnosis in African-Caribbean men. Psycho-Oncology,25, 1183–1190.
Seymour-Smith, S., Wetherell, M., & Phoenix, A. (2002). My wife ordered me to come: A discursive analysis of doctors’ and nurses’ accounts of men’s use of general practitioners. Journal of Health Psychology, 7(3), 253–276.
Sinfield, P., et al. (2009). Men’s and carers’ experiences of care for prostate cancer: A narrative literature review. Health Expectations,12, 301–312.
Soloway, C. T., Soloway, M. S., Kim, S. S., & Kava, B. R. (2005). Sexual, psychological and dyadic qualities of the prostate cancer ‘couple’. BJU International,95(6), 780–785.
Stanford, J. L., Feng, Z., Hamilton, A. S., Gilliland, F. D., Stephenson, R. A., Eley, J. W., et al. (2000). Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The prostate cancer outcomes study. Journal of the American Medical Association,283, 354–360.
Stansbury, J. P., Mathewson-Chapman, M., & Grant, K. E. (2005). Gender schema and prostate cancer: Veterans’ cultural model of masculinity. Medical Anthropology,22, 175–204.
Steer, A. N., Aherne, N. J., Gorzynska, K., Hoffman, M., Last, A., Hill, J., et al. (2013). Decision regret in men undergoing dose-escalated radiation therapy for prostate cancer. International Journal of Radiation Oncology, 86(4), 716–720.
Thompson, R. (2014). Hear me now one year on. BME Cancer Communities. Retrieved May 31, 2018, from https://bmecancer.co.uk/reports/hmn_year.pdf.
Weinrich, S. P., Boyd, M. D., Bradford, D., et al. (1998). Recruitment of African Americans into prostate cancer screening. Cancer Practice,6(1), 23–30.
Wiechno, P. J., Sadowska, M., Kalinowksi, T., Michalski, W., & Demkow, T. (2013). Does pharmacological castration as adjuvant therapy for prostate cancer after radiotherapy affect anxiety and depression levels, cognitive functions and quality of life? Psycho-Oncology,22, 346–351.
Williams, K. C., Hicks, E. M., Chang, N., Connor, S. E., & Maliski, S. L. (2014). Purposeful normalization when caring for husbands recovering from prostate cancer. Qualitative Health Research,24(3), 306–316.
Winterich, J. A., Grzywacz, J. G., Quandt, S. A., Clark, P. E., Miller, D. P., Acuña, J., et al. (2009). Men’s knowledge and beliefs about prostate cancer: Education, race, and screening status. Ethnicity and Disease,19(2), 199–203.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 The Author(s)
About this chapter
Cite this chapter
Gannon, K. (2019). Men’s Health and Cancer—The Case of Prostate Cancer. In: Barry, J.A., Kingerlee, R., Seager, M., Sullivan, L. (eds) The Palgrave Handbook of Male Psychology and Mental Health. Palgrave Macmillan, Cham. https://doi.org/10.1007/978-3-030-04384-1_8
Download citation
DOI: https://doi.org/10.1007/978-3-030-04384-1_8
Published:
Publisher Name: Palgrave Macmillan, Cham
Print ISBN: 978-3-030-04383-4
Online ISBN: 978-3-030-04384-1
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)